Sort   by:  
 Page size 
UnknownPredictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.
Not available
S-EPMC9806434 | biostudies-literature
UnknownSorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial.
Not available
S-EPMC3950852 | biostudies-literature
UnknownImpact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial.
Not available
S-EPMC6718524 | biostudies-literature
UnknownNeoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trial.
Not available
S-EPMC4497499 | biostudies-literature
UnknownContinuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.
Not available
S-EPMC6440242 | biostudies-literature
UnknownFFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients.
Not available
S-EPMC4550302 | biostudies-literature
UnknownEfficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Not available
S-EPMC9999055 | biostudies-literature
UnknownInference and reconstruction of the heimdallarchaeial ancestry of eukaryotes.
Not available
S-EPMC10307638 | biostudies-literature
UnknownPredictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study.
Not available
S-EPMC11497430 | biostudies-literature
UnknownFive-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Not available
S-EPMC9437831 | biostudies-literature
Sort   by:  
 Page size